₁₀Bernard Flourié

Summary for 2004 [at-glance overview of Bernard Flourié work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Bernard Flourié. According to available data, in 2004 Bernard Flourié published at least 10 articles. This work was completed in collaboration with several authors including Bouhnik, Yoram and Beaugerie, Laurent. Many other authors have collaborated with Bernard Flourié as well. There is no information about the funding or the grants awarded to support this work.

Bernard Flourié is a key opinion leader in the specific area of Colitis, Ulcerative. This author's rank is 2 when compared to all other authors using the same keyword. Analysis of the article abstracts and the titles suggests that Bernard Flourié professional interests are focused around "treatment ulcerative colitis", "crohn disease lifetime" and "nondigestible carbohydrates stimulate". These might also be referred to as "ulcerative colitis", "crohn disease" or "treatment ulcerative". Statistical analysis shows that Bernard Flourié's writing is likely to contains terms "treatment", "colitis", "ulcerative", "patients", "disease" and "infliximab".

Unfortunately, there is not enough information to establish Bernard Flourié affiliation. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Bernard Flourié]

Do you know Bernard Flourié who matches the profile above? Click the photo and let us know!

Alternative names (0) [other authors with names similar to Bernard Flourié]

none

Year 2004 Charts [Bernard Flourié frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Bernard Flourié publication and funding history for the range of years]

Emails (3) [email addresses extracted from Bernard Flourié affiliations]

hidden to prevent spam, click here to reveal

Bernard Flourié Coauthors (30) [all coauthors with the number of joint publications]

5

4

4

4

₁₂Reimund, Jean-Marie

4

3

3

2

2

1

1

1

1

1

1

1

1

₅Lavergne-Slove, Anne

1

₄Coffin, Benoit

1

₄Dapoigny, Michel

1

₃Brouns, Fred

1

₃Bruley des Varannes, Stanislas

1

1

1

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (9) [condensed summary of the Bernard Flourié affiliations, the leading number and the color conveys importance]

₂Service d'hépato-gastroentérologie, Hôpital Européen Georges Pompidou, 75015 Paris.
₁Department of Gastroenterology and the Therapeutic Research Unit, Hôpital Lariboisière, Paris, France.
₁Service d'hépato-gastroentérologie, CH Lyon SUD, 69495 Pierre Bénite.
₁Service de gastroentérologie, Hôpital Saint Louis, 75010 Paris.
₁Département médico-chirurgical de pathologie digestive, Institut Mutualiste Montsouris, 75014 Paris.
₁CHU Hôtel-Dieu, Clermont-Ferrand, France.
₁Unité Inserm 407, Faculté de médecine Lyon Sud, Oullins.
₁Service de Médecine Nucléaire, Centre Hospitalier Lyon-Sud, Pierre-Bénite.
₁Hospices Civils de Lyon, Lyonn Cedex, France.

Key Opinion Leader In [Bernard Flourié is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₂Colitis, Ulcerative | ₂₀Colon | ₁₄₇Severity of Illness Index | ₂₃₅Immunosuppressive Agents

Keywords (32) [keywords assigned to Bernard Flourié articles by PubMed, the leading number and the color conveys importance]

₁₀Humans | ₇Colitis, Ulcerative | ₅Adult | ₅Female | ₄Severity of Illness Index | ₄Middle Aged | ₄Male | ₃Colon | ₃Immunosuppressive Agents | ₂Adolescent | ₂Retrospective Studies | ₂Acute Disease | ₂Digestive System Surgical Procedures | ₂Practice Guidelines as Topic | ₂Drug Therapy, Combination | ₂Aged | ₂Prognosis | ₁Oligosaccharides | ₁Technetium Tc 99m Exametazime | ₁Colonic Diseases | ₁Sensitivity and Specificity | ₁Bifidobacterium | ₁Glucocorticoids | ₁Sex Distribution | ₁Questionnaires | ₁Postoperative Care | ₁Azathioprine | ₁Starch | ₁Feces | ₁France | ₁Irritable Bowel Syndrome | ₁Infusions, Intravenous

Bernard Flourié Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Bernard Flourié might be a good expert witness on these terms]

₁₀treatment | ₉colitis | ₉ulcerative | ₈patients | ₆disease | ₆infliximab | ₆severe | ₆uc | ₆study | ₆therapy | ₆subjects | ₅acute | ₅clinical | ₅euros | ₅analysis | ₅life | ₅patient | ₄management | ₄crohn | ₄cost-utility | ₄active | ₄per | ₄effect | ₄criteria | ₄conclusion | ₄endoscopic | ₄appearance | ₄severity | ₃azathioprine | ₃randomized | ₃methods | ₃chronic
₉ulcerative colitis | ₄crohn disease | ₄treatment ulcerative | ₃chronic active | ₃severe acute | ₃cost-utility analysis | ₂99mtc-hmpao granulocyte | ₂acute uc | ₂scintigraphic double-track | ₂endoscopic examination | ₂carbohydrates stimulate | ₂acute episodes | ₂episodes ulcerative | ₂randomized placebo-controlled | ₂common debilitating | ₂bifidobacteria healthy | ₂intravenous followed | ₂parallel-group dose-response | ₂healthy humans | ₂per cent | ₂infliximab therapy | ₂fecal bifidobacteria | ₂active ulcerative | ₂lifetime cost-utility | ₂double-blind randomized | ₂severity attacks | ₂double-track appearance | ₂granulocyte scintigraphy | ₂combined azathioprine | ₂placebo-controlled parallel-group | ₂followed oral | ₂irritable bowel
₄treatment ulcerative colitis | ₂crohn disease lifetime | ₂nondigestible carbohydrates stimulate | ₂capacity nondigestible carbohydrates | ₂placebo-controlled parallel-group dose-response | ₂fecal bifidobacteria healthy | ₂management severe crohn | ₂chronic active ulcerative | ₂acute episodes ulcerative | ₂dose-response relation study | ₂severe acute episodes | ₂sign severe acute | ₂efficacy intravenous followed | ₂appearance sign severe | ₂double-track appearance sign | ₂99mtc-hmpao granulocyte scintigraphy | ₂humans double-blind randomized | ₂disease lifetime cost-utility | ₂syndrome france common | ₂debilitating costly disorder | ₂oral cyclosporine combined | ₂stimulate fecal bifidobacteria | ₂double-blind randomized placebo-controlled | ₂cyclosporine combined azathioprine | ₂severe crohn disease | ₂lifetime cost-utility analysis | ₂common debilitating costly | ₂scintigraphic double-track appearance | ₂irritable bowel syndrome | ₂bifidobacteria healthy humans | ₂france common debilitating | ₂intravenous followed oral

Reader's Comments (0) [comments posted by readers of Bernard Flourié profile]